Biotechnology company launches cancer vaccine trial for dogs
A new vaccine trial for canines with early stage hemangiosarcoma (HSA) is underway. Calviri, a biotechnology company that creates therapeutic and preventative cancer vaccines for dogs and humans, announced it has vaccinated its first participant with its …